The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study.
Lichtman, Stuart M
The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study. [electronic resource] - Cancer investigation 2002 - 904-13 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
0735-7907
10.1081/cnv-120005903 doi
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--pharmacokinetics
Area Under Curve
Creatinine--metabolism
Dose-Response Relationship, Drug
Female
Humans
Injections, Intravenous
Kidney Failure, Chronic--metabolism
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Metabolic Clearance Rate
Middle Aged
Prospective Studies
Vidarabine Phosphate--analogs & derivatives
The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study. [electronic resource] - Cancer investigation 2002 - 904-13 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study
0735-7907
10.1081/cnv-120005903 doi
Adult
Aged
Aged, 80 and over
Antimetabolites, Antineoplastic--pharmacokinetics
Area Under Curve
Creatinine--metabolism
Dose-Response Relationship, Drug
Female
Humans
Injections, Intravenous
Kidney Failure, Chronic--metabolism
Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy
Lymphoma, Non-Hodgkin--drug therapy
Male
Metabolic Clearance Rate
Middle Aged
Prospective Studies
Vidarabine Phosphate--analogs & derivatives